Related Experiment Videos
Indications for partial left ventriculectomy in pediatric dilated cardiomyopathy
Shinpei Yoshii1, Shigeru Hosaka, Shoji Suzuki
1Department of Surgery, Yamanashi Medical University, Japan. syoshii@res.yamanashi-med.ac.jp
Summary
Partial left ventriculectomy (PLV) can be a viable option for children with end-stage dilated cardiomyopathy (DCM) when medical therapy fails and heart transplantation is not accessible. Careful patient selection is crucial for successful outcomes.
Area of Science:
- Pediatric Cardiology
- Cardiothoracic Surgery
Background:
- Dilated cardiomyopathy (DCM) in children presents significant management challenges, often progressing to end-stage heart failure.
- Limited therapeutic options exist for pediatric DCM when medical management is insufficient.
Purpose of the Study:
- To define the role and indications of partial left ventriculectomy (PLV) in pediatric patients with end-stage dilated cardiomyopathy (DCM).
Main Methods:
- Retrospective chart review of pediatric DCM patients treated between 1997 and 2000.
- Comparison of outcomes between patients who underwent PLV (PLV group) and those managed non-surgically (non-PLV group).
- Analysis of clinical data including preoperative status, cardiac dimensions, ejection fraction, and serum biomarkers.
Main Results:
- Two of four PLV patients remained well long-term; one underwent successful heart transplantation, and one died postoperatively.
- Non-PLV patients were managed with medical therapy or mitral valve replacement, with generally better cardiac function indicators.
- PLV group showed significantly higher cardiothoracic ratios, left ventricular diastolic dimensions, and serum brain natriuretic peptide levels compared to the non-PLV group.
Conclusions:
- Partial left ventriculectomy is indicated for select pediatric patients with end-stage DCM.
- PLV is most appropriate when medical therapy is ineffective and heart transplantation is unavailable.
- Preoperative status, particularly urgent vs. elective surgery, impacts outcomes in PLV patients.